Clinical Trial Update: Efficacy and Safety of Dexmedetomidine Added to Modified Pectoral's Block in Breast Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of adding dexmedetomidine to a modified pectoral block in breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: South Egypt Cancer Institute | Conditions: Breast Cancer Patients | Phase 3 | Status: UNKNOWN